
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
Marta Bertran, Zahin Amin‐Chowdhury, Carmen Sheppard, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 8, pp. 1669-1672
Open Access | Times Cited: 86
Marta Bertran, Zahin Amin‐Chowdhury, Carmen Sheppard, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 8, pp. 1669-1672
Open Access | Times Cited: 86
Showing 1-25 of 86 citing articles:
Epidemiology of Respiratory Infections during the COVID-19 Pandemic
Nicola Principi, Giovanni Autore, Greta Ramundo, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1160-1160
Open Access | Times Cited: 74
Nicola Principi, Giovanni Autore, Greta Ramundo, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1160-1160
Open Access | Times Cited: 74
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
David R. Shaw, Raquel Abad, Zahin Amin‐Chowdhury, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 9, pp. e582-e593
Open Access | Times Cited: 69
David R. Shaw, Raquel Abad, Zahin Amin‐Chowdhury, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 9, pp. e582-e593
Open Access | Times Cited: 69
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Rose G Bender, Sarah Brooke Sirota, Lucien R Swetschinski, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 974-1002
Open Access | Times Cited: 68
Rose G Bender, Sarah Brooke Sirota, Lucien R Swetschinski, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 974-1002
Open Access | Times Cited: 68
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
Miwako Kobayashi, Tamara Pilishvili, Jennifer L. Farrar, et al.
MMWR Recommendations and Reports (2023) Vol. 72, Iss. 3, pp. 1-39
Open Access | Times Cited: 63
Miwako Kobayashi, Tamara Pilishvili, Jennifer L. Farrar, et al.
MMWR Recommendations and Reports (2023) Vol. 72, Iss. 3, pp. 1-39
Open Access | Times Cited: 63
Changing patterns of infectious diseases in children during the COVID-19 pandemic
Ming‐Chun Yang, Yu‐Tsun Su, Ping-Hong Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 45
Ming‐Chun Yang, Yu‐Tsun Su, Ping-Hong Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 45
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study
Marta Bertran, Joshua C D'Aeth, Fariyo Abdullahi, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 546-556
Open Access | Times Cited: 42
Marta Bertran, Joshua C D'Aeth, Fariyo Abdullahi, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 546-556
Open Access | Times Cited: 42
All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) compared with the pre-pandemic period (2015–19) in South Africa: an observational study
Alane Izu, Marta C. Nunes, Fatima Solomon, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 9, pp. 1031-1041
Open Access | Times Cited: 38
Alane Izu, Marta C. Nunes, Fatima Solomon, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 9, pp. 1031-1041
Open Access | Times Cited: 38
Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present
Elizabeth Hamson, Carol Forbes, Priscilla Geraldine Wittkopf, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 38
Elizabeth Hamson, Carol Forbes, Priscilla Geraldine Wittkopf, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 38
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial
Dorota Borys, Richard Rupp, Ronald Smulders, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2560-2571
Open Access | Times Cited: 8
Dorota Borys, Richard Rupp, Ronald Smulders, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2560-2571
Open Access | Times Cited: 8
Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study
Yoon Hong Choi, Marta Bertran, D Litt, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e654-e663
Open Access | Times Cited: 8
Yoon Hong Choi, Marta Bertran, D Litt, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e654-e663
Open Access | Times Cited: 8
Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England
S. A. Clark, Helen Campbell, Sonia Ribeiro, et al.
Journal of Infection (2023) Vol. 87, Iss. 5, pp. 385-391
Open Access | Times Cited: 18
S. A. Clark, Helen Campbell, Sonia Ribeiro, et al.
Journal of Infection (2023) Vol. 87, Iss. 5, pp. 385-391
Open Access | Times Cited: 18
Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020–2022
Leah J. Ricketson, James D. Kellner
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1333-1333
Open Access | Times Cited: 16
Leah J. Ricketson, James D. Kellner
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1333-1333
Open Access | Times Cited: 16
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants
Sophie Warren, Myrto Barmpouni, Vasiliki Kossyvaki, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1369-1369
Open Access | Times Cited: 15
Sophie Warren, Myrto Barmpouni, Vasiliki Kossyvaki, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1369-1369
Open Access | Times Cited: 15
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 15
James Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 785-800
Open Access | Times Cited: 15
Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes
Catarina Silva-Costa, Joana Gomes-Silva, Marcos D. Pinho, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106242-106242
Closed Access | Times Cited: 6
Catarina Silva-Costa, Joana Gomes-Silva, Marcos D. Pinho, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106242-106242
Closed Access | Times Cited: 6
Calendario de vacunaciones e inmunizaciones de la Asociación Española de Pediatría: recomendaciones 2025
Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, et al.
Anales de Pediatría (2025) Vol. 102, Iss. 1, pp. 503713-503713
Open Access
Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, et al.
Anales de Pediatría (2025) Vol. 102, Iss. 1, pp. 503713-503713
Open Access
Immunisation schedule of the Pediatric Spanish Association: 2024 recommendations
Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, et al.
Anales de Pediatría (English Edition) (2025) Vol. 102, Iss. 1, pp. 503713-503713
Open Access
Francisco José Álvarez García, Antonio Iofrío de Arce, Javier Álvarez Aldeán, et al.
Anales de Pediatría (English Edition) (2025) Vol. 102, Iss. 1, pp. 503713-503713
Open Access
Verification of Immune Debts in Children Caused by the COVID-19 Pandemic from an Epidemiological and Clinical Perspective
Masayuki Nagasawa
Immuno (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access
Masayuki Nagasawa
Immuno (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Alane Izu, Eleonora A.M.L. Mutsaerts, Courtney P. Olwagen, et al.
Expert Review of Vaccines (2025) Vol. 24, Iss. 1, pp. 121-127
Open Access
Alane Izu, Eleonora A.M.L. Mutsaerts, Courtney P. Olwagen, et al.
Expert Review of Vaccines (2025) Vol. 24, Iss. 1, pp. 121-127
Open Access
Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan
Chyi-Liang Chen, Yi-Ching Chen, Hsuan-Ling Hsiao, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42229-e42229
Open Access
Chyi-Liang Chen, Yi-Ching Chen, Hsuan-Ling Hsiao, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42229-e42229
Open Access
Incidence Rates for Invasive Streptococcus pneumoniae and Haemophilus influenzae Infections in US Military Pediatric Dependents Before and During COVID-19
Matthew PENFOLD, Sarah Prabhakar, Michael Rajnik, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 225-225
Open Access
Matthew PENFOLD, Sarah Prabhakar, Michael Rajnik, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 225-225
Open Access
Isolation and Epidemiology of Respiratory Bacteria From Unusual Sites: Demographic, Seasonal, and Geographic Distribution in a Laboratory-Based Study From a Tertiary Care Hospital in Karachi, Pakistan
Syeda Rida E zehra, Salman Khan, Sardar Azhar Mehmood, et al.
Cureus (2025)
Open Access
Syeda Rida E zehra, Salman Khan, Sardar Azhar Mehmood, et al.
Cureus (2025)
Open Access
Impact of the COVID-19 pandemic on invasive pneumococcal disease in American Indian communities in the Southwest US
Catherine G. Sutcliffe, Shea Littlepage, Del Yazzie, et al.
Journal of Medical Microbiology (2025) Vol. 74, Iss. 3
Closed Access
Catherine G. Sutcliffe, Shea Littlepage, Del Yazzie, et al.
Journal of Medical Microbiology (2025) Vol. 74, Iss. 3
Closed Access
The direct impact of mandatory PCV10 vaccination on invasive pneumococcal disease in Polish children
Anna Skoczyńska, Agnieszka Gołębiewska, Izabela Wróbel-Pawelczyk, et al.
Vaccine (2025) Vol. 54, pp. 126999-126999
Closed Access
Anna Skoczyńska, Agnieszka Gołębiewska, Izabela Wróbel-Pawelczyk, et al.
Vaccine (2025) Vol. 54, pp. 126999-126999
Closed Access
Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species — United States, January 2016–August 2022
Emma K. Accorsi, Sopio Chochua, Heidi L Moline, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 37, pp. 1169-1173
Open Access | Times Cited: 25
Emma K. Accorsi, Sopio Chochua, Heidi L Moline, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 37, pp. 1169-1173
Open Access | Times Cited: 25